Hepion Pharmaceuticals Is A Clinical Stage Biopharmaceutical Company Focused On Developing Therapies For Chronic Liver Diseases Using Artificial Intelligenceformerly Known As Contravir Pharmaceuticalsthe Company Has Rebranded To Highlight Its Commitment To Addressing Hepatic Disordershepion Utilizes Its Proprietary Ai Powra C Platform To Enhance Drug Development By Decoding Disease Mechanisms And Optimizing Therapeutic Candidates The Company S Lead Drug Candidaterencofilstatcrv431 Is A Cyclophilin Inhibitor Currently In Phase 2 Clinical Trials For Non Alcoholic Steatohepatitisnash It Has Received Fast Track And Orphan Drug Designations From The Fda For Nash And Hepatocellular Carcinomahcc Hepion S Pipeline Includes Several Clinical Stage Candidates Targeting Both Nash And Hccthe Company Aims To Serve Patients And Healthcare Providers By Addressing Significant Unmet Needs In Chronic Liver Diseaseswhich Impact Over 500 Million People Worldwide
